MII IG Kerndatensatz-Modul Molekulares Tumorboard
2027.0.0-ballot.1 - Germany

This page is part of the MII Implementation Guide Molecular Tumor Board (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: PatientKimMusterperson-MolecularPathologyInterpret-0a-Her2neu

English

Profile: MII PR MTB Immunohistochemistry version: 2027.0.0-ballot.1

status: Final

category: Laboratory, A characterization of a given biomarker observation.

code: HER2 Ag [Interpretation] in Tissue

subject: Kim Musterperson (no stated gender), DoB: 1956-03-14

value: HER2-low (IHC 2+/ISH negative)

specimen: Specimen: accessionIdentifier = Z230201/23; type = Ascitic fluid specimen (specimen)

Components

-CodeValue[x]
*Gene studied [ID]ERBB2